Clinical Trial Update: Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on fibroblast growth factor-1 (FGF-1) for treating coronary disease shows ongoing investigation with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Arteriosclerosis
• Coronary Disease
• Coronary Heart Disease
• Myocardial Ischemia

Drugs mentioned

• Fibroblast Growth Factor-1 (FGF-1)

Snippet

Sponsor: CardioVascular BioTherapeutics, Inc. | Conditions: Coronary Disease, Coronary Heart Disease | Phase 2 | Status: UNKNOWN